Analysis of toll-like receptor-dependent production of proinflammatory cytokines in vitro by human peripheral blood mononuclears of donors and patients with primary immunodeficiency

Bulletin of Experimental Biology and Medicine

Volumn 144, Issue 1, 2007, Pages 63-65

  Koval'chuk, L V ^a   Khoreva, M V ^a   Varivoda, A S ^a   Pashchenko, O E ^b   Gracheva, L A ^b   Bykova, L P ^b   Kondratenko, I V ^b   Bologov, A A ^b  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b Russian Pediatric Clinical Hospital   (Russian Federation)

Author keywords

Common variable immunodeficiency; Interferon ; Mononuclear cells; Toll like receptors; Tumornecrosis factor

Indexed keywords

ALPHA INTERFERON; ANTIINFECTIVE AGENT; CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; FLAGELLIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIGAND; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DONOR; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; LYMPHOCYTE COUNT; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; SCHOOL CHILD;

ADOLESCENT; ADULT; BLOOD DONORS; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; FLAGELLIN; HUMANS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; OLIGODEOXYRIBONUCLEOTIDES; POLY I-C; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

EID: 36348962966     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-007-0255-z     Document Type: Article

References (13)

1. L. V. Koval'chuk, M. V. Khoreva, and A. S. Varivoda, Zh. Mikrobiol. Epidemiol. Immunol., No. 4, 96-104 (2005).
2. V. A. D'yakonova, S. V. Dambaeva, N. M. Golubeva, et al., Fiziologiya i Patologiya Immun. Sist., No. 2, 100-115 (2004).
3. S. Akira and K. Takeda, Nat. Rev. Immunol., 4, No. 7, 499-511 (2004).
4. P. Aukrust, E. Lien, A. K. Kristoffersen, et al., Blood, 87, No. 2, 674-681 (1996).
5. J. Bayry, S. Lacroix-Desmazes, M. D. Kazatchkine, et al., Ibid., 104, No. 8, 2441-2443 (2004).
6. C. Cunningham-Rundles and L. Radigan, Clin. Immunol., 115, No. 2, 147-153 (2005).
7. C. Cunningham-Rundles, L. Radigan, A. K. Knight, et al., J. Immunol., 176, No. 3, 1978-1987 (2006).
8. R. P. Deering and J. S. Orange, Clin. Vaccine Immunol., 13, No. 1, 68-76 (2006).
9. A. Iwasaki and R. Medzhitov, Nat. Immunol., 5, No. 10, 987-995 (2004).
10. P. Lenert, Clin. Exp. Immunol., 140, No. 1, 1-10 (2005).
11. O. Levy, K. A. Zarember, R. M. Roy, et al., J. Immunol., 173, No. 7, 4627-4634 (2004).
12. K. Takeda and S. Akira, Int. Immunol., 17, No. 1, 1-14 (2005).
13. D. Viemann, G. Dubbel, S. Schleifenbaum, et al., Pediatr. Res., 58, No. 4, 654-657 (2005).